The NH2-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl

Molecular and Cellular Biology

Volumn 21, Issue 3, 2001, Pages 840-853

  Zhang, X ^a   Subrahmanyam, R ^a   Wong, R ^a   Gross, A W ^a   Ren, R ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CHRONIC MYELOID LEUKEMIA; GENETIC LINKAGE; LEUKEMOGENESIS; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BASE SEQUENCE; BINDING SITES; BONE MARROW TRANSPLANTATION; CELL LINE; DNA PRIMERS; FUSION PROTEINS, BCR-ABL; GRB2 ADAPTOR PROTEIN; MICE; MYELOPROLIFERATIVE DISORDERS; PROTEIN STRUCTURE, TERTIARY; PROTEINS; TRANSDUCTION, GENETIC; TYROSINE;

ANIMALIA; MURINAE;

EID: 0035136290     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.3.840-853.2001     Document Type: Article

References (50)

1. Differential complementation of Bcr-Abl point mutants with c-Myc
2. The SH2-containing adapter protein GRB10 interacts with BCR-ABL
3. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl
4. TEL-JAK2 transgenic mice develop T-cell leukemia
5. Structural and signaling requirements for BCR-ABL-mediated transformation and inhibition of apoptosis
6. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome
7. Nonmyristoylated Abl proteins transform a factor-dependent hematopoietic cell line
8. Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions
9. bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice
10. The biology of chronic myeloid leukemia
11. Deletion of an N-terminal regulatory domain of the c-abl tyrosine kinase activates its oncogenic potential
12. Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene
13. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia
14. Bcr-Abl with an SH3 deletion retains the ability to induce a myeloproliferative disease in mice, yet c-Abl activated by an SH3 deletion induces only lymphoid malignancy
15. Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder
16. Acute leukemia in bcr/abl transgenic mice
17. Expression of p210bcr-abl by metallothionein promoter induced T-cell leukemia in transgenic mice
18. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: A novel transgenic model for human Ph1-positive leukemias
19. Acquired loss of p53 induces blastic transformation in p210(bcr/abl)-expressing hematopoietic cells: A transgenic study for blast crisis of human CML
20. Reversibility of acute B-cell leukaemia induced by BCR-ABL1
21. N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl
22. Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL
23. The molecular genetics of Philadelphia chromosome-positive leukemias
24. The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity
25. BCR-ABL tyrosine kinase is autophosphorylated or transphosphorylates P160 BCR on tyrosine predominantly within the first BCR exon
26. Inhibition of Bcr serine kinase by tyrosine phosphorylation
27. The SH2 and SH3 domains containing protein GRB2 links receptor tyrosine kinases to ras signaling
28. Deletion of the ABL SH3 domain reactivates de-oligomerized BCR-ABL for growth factor independence
29. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase
30. A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins
31. Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteins
32. Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoprotein
33. BCR-ABL gene variants
34. The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr/Abl tyrosine kinase
35. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias
36. The novel activation of ABL by fusion to an ets-related gene
37. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow
38. Production of high-titer helper-free retroviruses by transient transfection
39. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein
40. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway
41. Signal transduction by wild-type and leukemogenic Abl proteins
42. Abl protein-tyrosine kinase selects the Crk adapter as a substrate using SH3-binding sites
43. Chronic myeloid leukemia
44. The tetramerization domain-independent Ras activation by BCR-ABL oncoprotein in hematopoietic cells
45. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581
46. Integrin-mediated regulation of hematopoiesis: Do BCR/ABL-induced defects in integrin function underlie the abnormal circulation and proliferation of CML progenitors?
47. BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice
48. Non-globular domains in protein sequences: Automated segmentation using complexity measures
49. Requirement of two specific tyrosine residues for the catalytic activity of Bcr serine/threonine kinase
50. Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: A novel model for chronic myelogenous leukemia